Prime Therapeutics Program Posts 9:1 ROI

April 27, 2020

A program by Prime Therapeutics posted a 9:1 return on the original investment, the PBM announced.

According to a press release, the program ultimately resulted in $2.4 million in savings on health costs.

To read the press release, click here.

Share This Story!